Literature DB >> 22936357

Acellular normal and fibrotic human lung matrices as a culture system for in vitro investigation.

Adam J Booth1, Ryan Hadley, Ashley M Cornett, Alyssa A Dreffs, Stephanie A Matthes, Jessica L Tsui, Kevin Weiss, Jeffrey C Horowitz, Vincent F Fiore, Thomas H Barker, Bethany B Moore, Fernando J Martinez, Laura E Niklason, Eric S White.   

Abstract

RATIONALE: Extracellular matrix (ECM) is a dynamic tissue that contributes to organ integrity and function, and its regulation of cell phenotype is a major aspect of cell biology. However, standard in vitro culture approaches are of unclear physiologic relevance because they do not mimic the compositional, architectural, or distensible nature of a living organ. In the lung, fibroblasts exist in ECM-rich interstitial spaces and are key effectors of lung fibrogenesis.
OBJECTIVES: To better address how ECM influences fibroblast phenotype in a disease-specific manner, we developed a culture system using acellular human normal and fibrotic lungs.
METHODS: Decellularization was achieved using treatment with detergents, salts, and DNase. The resultant matrices can be sectioned as uniform slices within which cells were cultured.
MEASUREMENTS AND MAIN RESULTS: We report that the decellularization process effectively removes cellular and nuclear material while retaining native dimensionality and stiffness of lung tissue. We demonstrate that lung fibroblasts reseeded into acellular lung matrices can be subsequently assayed using conventional protocols; in this manner we show that fibrotic matrices clearly promote transforming growth factor-β-independent myofibroblast differentiation compared with normal matrices. Furthermore, comprehensive analysis of acellular matrix ECM details significant compositional differences between normal and fibrotic lungs, paving the way for further study of novel hypotheses.
CONCLUSIONS: This methodology is expected to allow investigation of important ECM-based hypotheses in human tissues and permits future scientific exploration in an organ- and disease-specific manner.

Entities:  

Mesh:

Year:  2012        PMID: 22936357      PMCID: PMC3530219          DOI: 10.1164/rccm.201204-0754OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  48 in total

1.  Cell traction forces direct fibronectin matrix assembly.

Authors:  Christopher A Lemmon; Christopher S Chen; Lewis H Romer
Journal:  Biophys J       Date:  2009-01       Impact factor: 4.033

2.  Integrin alpha8beta1 mediates adhesion to LAP-TGFbeta1.

Authors:  Min Lu; John S Munger; Melissa Steadele; Christina Busald; Marinka Tellier; Lynn M Schnapp
Journal:  J Cell Sci       Date:  2002-12-01       Impact factor: 5.285

3.  Tissue-engineered lungs for in vivo implantation.

Authors:  Thomas H Petersen; Elizabeth A Calle; Liping Zhao; Eun Jung Lee; Liqiong Gui; MichaSam B Raredon; Kseniya Gavrilov; Tai Yi; Zhen W Zhuang; Christopher Breuer; Erica Herzog; Laura E Niklason
Journal:  Science       Date:  2010-06-24       Impact factor: 47.728

Review 4.  Chronic liver injury, TGF-beta, and cancer.

Authors:  D M Bissell
Journal:  Exp Mol Med       Date:  2001-12-31       Impact factor: 8.718

Review 5.  Mouse models of genetic diseases resulting from mutations in elastic fiber proteins.

Authors:  H C Dietz; R P Mecham
Journal:  Matrix Biol       Date:  2000-11       Impact factor: 11.583

Review 6.  Murine models of pulmonary fibrosis.

Authors:  Bethany B Moore; Cory M Hogaboam
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-11-09       Impact factor: 5.464

7.  Fibronectin requirement in branching morphogenesis.

Authors:  Takayoshi Sakai; Melinda Larsen; Kenneth M Yamada
Journal:  Nature       Date:  2003-06-19       Impact factor: 49.962

Review 8.  Pulmonary fibrosis: pathogenesis, etiology and regulation.

Authors:  M S Wilson; T A Wynn
Journal:  Mucosal Immunol       Date:  2009-01-07       Impact factor: 7.313

Review 9.  A tense situation: forcing tumour progression.

Authors:  Darci T Butcher; Tamara Alliston; Valerie M Weaver
Journal:  Nat Rev Cancer       Date:  2009-02       Impact factor: 60.716

10.  Clinical transplantation of a tissue-engineered airway.

Authors:  Paolo Macchiarini; Philipp Jungebluth; Tetsuhiko Go; M Adelaide Asnaghi; Louisa E Rees; Tristan A Cogan; Amanda Dodson; Jaume Martorell; Silvia Bellini; Pier Paolo Parnigotto; Sally C Dickinson; Anthony P Hollander; Sara Mantero; Maria Teresa Conconi; Martin A Birchall
Journal:  Lancet       Date:  2008-11-18       Impact factor: 79.321

View more
  225 in total

Review 1.  Revascularization of decellularized lung scaffolds: principles and progress.

Authors:  Collin T Stabler; Shimon Lecht; Mark J Mondrinos; Ernesto Goulart; Philip Lazarovici; Peter I Lelkes
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-09-25       Impact factor: 5.464

2.  Production of decellularized porcine lung scaffolds for use in tissue engineering.

Authors:  Jenna L Balestrini; Ashley L Gard; Angela Liu; Katherine L Leiby; Jonas Schwan; Britta Kunkemoeller; Elizabeth A Calle; Amogh Sivarapatna; Tylee Lin; Sashka Dimitrievska; Stuart G Cambpell; Laura E Niklason
Journal:  Integr Biol (Camb)       Date:  2015-10-01       Impact factor: 2.192

Review 3.  In Vitro Models to Study Human Lung Development, Disease and Homeostasis.

Authors:  Alyssa J Miller; Jason R Spence
Journal:  Physiology (Bethesda)       Date:  2017-05

4.  Decellularized Human Lung Scaffolds as Complex Three-Dimensional Tissue Culture Models to Study Functional Behavior of Fibroblasts.

Authors:  Gerald Burgstaller; Michael Gerckens; Oliver Eickelberg; Melanie Königshoff
Journal:  Methods Mol Biol       Date:  2021

5.  Reconstituting Mouse Lungs with Conditionally Reprogrammed Human Bronchial Epithelial Cells.

Authors:  Ryan LaRanger; Jennifer R Peters-Hall; Melissa Coquelin; Busola R Alabi; Christopher T Chen; Woodring E Wright; Jerry W Shay
Journal:  Tissue Eng Part A       Date:  2017-09-25       Impact factor: 3.845

6.  The effect of age and emphysematous and fibrotic injury on the re-cellularization of de-cellularized lungs.

Authors:  Dino Sokocevic; Nicholas R Bonenfant; Darcy E Wagner; Zachary D Borg; Melissa J Lathrop; Ying Wai Lam; Bin Deng; Michael J Desarno; Taka Ashikaga; Roberto Loi; Andrew M Hoffman; Daniel J Weiss
Journal:  Biomaterials       Date:  2013-02-04       Impact factor: 12.479

7.  Protein Tyrosine Phosphatase-N13 Promotes Myofibroblast Resistance to Apoptosis in Idiopathic Pulmonary Fibrosis.

Authors:  Alison Bamberg; Elizabeth F Redente; Steve D Groshong; Rubin M Tuder; Carlyne D Cool; Rebecca C Keith; Benjamin L Edelman; Bart P Black; Gregory P Cosgrove; Murry W Wynes; Douglas Curran-Everett; Stijn De Langhe; Luis A Ortiz; Andrew Thorburn; David W H Riches
Journal:  Am J Respir Crit Care Med       Date:  2018-10-01       Impact factor: 21.405

Review 8.  Matrix remodeling in chronic lung diseases.

Authors:  Bon-Hee Gu; Matthew C Madison; David Corry; Farrah Kheradmand
Journal:  Matrix Biol       Date:  2018-03-17       Impact factor: 11.583

9.  Controlling stem cell behavior with decellularized extracellular matrix scaffolds.

Authors:  Gillie Agmon; Karen L Christman
Journal:  Curr Opin Solid State Mater Sci       Date:  2016-08       Impact factor: 11.354

10.  Microphysiological Systems: Design, Fabrication, and Applications.

Authors:  Kai Wang; Kun Man; Jiafeng Liu; Yang Liu; Qi Chen; Yong Zhou; Yong Yang
Journal:  ACS Biomater Sci Eng       Date:  2020-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.